Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Bin Tong, Yaoqi Ba, Zhengyang Li, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106505-106505
Open Access | Times Cited: 15
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies
Sagar Gaikwad, Sudipta Senapati, Md. Anzarul Haque, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 709-727
Open Access | Times Cited: 31
Navigating the dementia landscape: Biomarkers and emerging therapies
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102193-102193
Closed Access | Times Cited: 14
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
Zhouquan Jiang, Jing Wang, Yongpeng Qin, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
Tuancheng Feng, Huan Du, Cha Yang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 8
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease
Allison Carles, Aline Freyssin, Sarra Guehairia, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Sahar Balkhi, Antimo Di Spirito, Alessandro Poggi, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 264-264
Open Access | Times Cited: 1
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Vasu Peddinti, Manoj Mohan Avaghade, Sunil Suthar, et al.
Clinical Nutrition ESPEN (2024) Vol. 60, pp. 266-280
Closed Access | Times Cited: 7
The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
Jin Yang, Junyi Liang, Niyuan Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 7
Protein Kinase C (PKC) in Neurological Health: Implications for Alzheimer’s Disease and Chronic Alcohol Consumption
R.S. Kaler, Shouvik Kumar Nandy, Anupam Jyoti, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 554-554
Open Access | Times Cited: 6
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
Devin Wahl, Sydney Risen, Shelby C. Osburn, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Dietary salt promotes cognition impairment through GLP-1R/mTOR/p70S6K signaling pathway
Xu Yang, Shu Liu, Chuanling Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology
Sierra Jaye, Ursula S Sandau, Julie A. Saugstad
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Nodding syndrome: A role for environmental biotoxins that dysregulate MECP2 expression?
Peter S. Spencer, Raquel Valdes Angues, Valerie S. Palmer
Journal of the Neurological Sciences (2024) Vol. 462, pp. 123077-123077
Closed Access | Times Cited: 5
Linking evidence for targeted blood biomarkers in post-stroke cognitive impairment and dementia
Jie Hong, Katherine T Mun, Kyle C. Kern, et al.
Frontiers in Stroke (2025) Vol. 3
Open Access
Stereo-seq of the prefrontal cortex in aging and Alzheimer’s disease
Yun Gong, Mohammad Haeri, Xiao Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease
Peng Wang, Ying Dong, Shanshan Li, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease
Ashish Ghimire, Sayeed Ur Rehman, A. Subhani, et al.
hLife (2025)
Open Access
The Emerging Role of Mitochondria Oxygen Redox in Pathological Progression of Neurodegenerative Disorders
S. Li, Xueyan Gong, Ferdinand Ndikuryayo, et al.
Ageing Research Reviews (2025), pp. 102660-102660
Closed Access
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Novel peptidomimetic compounds attenuate hypoxic-ischemic brain injury in neonatal rats
Xiaodi Chen, Brynn Kroke, Jun Ni, et al.
Experimental Neurology (2025) Vol. 386, pp. 115151-115151
Closed Access
The potential link between the development of Alzheimer’s disease and osteoporosis
Fariha Nasme, Jyotirmaya Behera, Prisha Tyagi, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top